Logo image of RYDE

RYDE GROUP LTD-A (RYDE) Stock Fundamental Analysis

NYSEARCA:RYDE - KYG7733R1020 - Common Stock

0.2912 USD
-0.01 (-2.93%)
Last: 8/29/2025, 8:04:00 PM
0.2897 USD
0 (-0.52%)
After Hours: 8/29/2025, 8:04:00 PM
Fundamental Rating

3

Taking everything into account, RYDE scores 3 out of 10 in our fundamental rating. RYDE was compared to 41 industry peers in the Ground Transportation industry. RYDE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. RYDE is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

RYDE had negative earnings in the past year.
In the past year RYDE has reported a negative cash flow from operations.
RYDE Yearly Net Income VS EBIT VS OCF VS FCFRYDE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

With a Return On Assets value of -354.25%, RYDE is not doing good in the industry: 95.12% of the companies in the same industry are doing better.
RYDE has a worse Return On Equity (-810.17%) than 87.80% of its industry peers.
Industry RankSector Rank
ROA -354.25%
ROE -810.17%
ROIC N/A
ROA(3y)-188.67%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RYDE Yearly ROA, ROE, ROICRYDE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

RYDE has a Gross Margin of 50.67%. This is in the better half of the industry: RYDE outperforms 63.41% of its industry peers.
RYDE's Gross Margin has improved in the last couple of years.
RYDE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.1%
GM growth 5YN/A
RYDE Yearly Profit, Operating, Gross MarginsRYDE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -50 -100 -150 -200

More info and screens

5

2. Health

2.1 Basic Checks

RYDE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RYDE has more shares outstanding
There is no outstanding debt for RYDE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
RYDE Yearly Shares OutstandingRYDE Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M 25M
RYDE Yearly Total Debt VS Total AssetsRYDE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

RYDE has an Altman-Z score of -12.90. This is a bad value and indicates that RYDE is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of RYDE (-12.90) is worse than 90.24% of its industry peers.
There is no outstanding debt for RYDE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -12.9
ROIC/WACCN/A
WACC8.86%
RYDE Yearly LT Debt VS Equity VS FCFRYDE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M -5M -10M

2.3 Liquidity

RYDE has a Current Ratio of 1.60. This is a normal value and indicates that RYDE is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of RYDE (1.60) is better than 78.05% of its industry peers.
RYDE has a Quick Ratio of 1.60. This is a normal value and indicates that RYDE is financially healthy and should not expect problems in meeting its short term obligations.
RYDE's Quick ratio of 1.60 is fine compared to the rest of the industry. RYDE outperforms 78.05% of its industry peers.
Industry RankSector Rank
Current Ratio 1.6
Quick Ratio 1.6
RYDE Yearly Current Assets VS Current LiabilitesRYDE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for RYDE have decreased strongly by -92.69% in the last year.
RYDE shows a decrease in Revenue. In the last year, the revenue decreased by -4.12%.
Measured over the past years, RYDE shows a quite strong growth in Revenue. The Revenue has been growing by 13.05% on average per year.
EPS 1Y (TTM)-92.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-30.71%
Revenue 1Y (TTM)-4.12%
Revenue growth 3Y13.05%
Revenue growth 5YN/A
Sales Q2Q%-47.23%

3.2 Future

Based on estimates for the next years, RYDE will show a very strong growth in Earnings Per Share. The EPS will grow by 35.40% on average per year.
RYDE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.59% yearly.
EPS Next Y75.64%
EPS Next 2Y35.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year14.8%
Revenue Next 2Y17.59%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
RYDE Yearly Revenue VS EstimatesRYDE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2M 4M 6M 8M 10M
RYDE Yearly EPS VS EstimatesRYDE Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 -0.2 -0.4 -0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

RYDE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RYDE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RYDE Price Earnings VS Forward Price EarningsRYDE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RYDE Per share dataRYDE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1

4.3 Compensation for Growth

RYDE's earnings are expected to grow with 35.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.4%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RYDE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RYDE GROUP LTD-A

NYSEARCA:RYDE (8/29/2025, 8:04:00 PM)

After market: 0.2897 0 (-0.52%)

0.2912

-0.01 (-2.93%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryGround Transportation
Earnings (Last)04-28 2025-04-28/bmo
Earnings (Next)N/A N/A
Inst Owners1.79%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap9.94M
Analysts82.86
Price Target0.61 (109.48%)
Short Float %0.6%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)20.83%
EPS NY rev (3m)20.83%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.83%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.96
P/FCF N/A
P/OCF N/A
P/B 3.22
P/tB 3.96
EV/EBITDA N/A
EPS(TTM)-1.32
EYN/A
EPS(NY)-0.15
Fwd EYN/A
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS0.3
BVpS0.09
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -354.25%
ROE -810.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.67%
FCFM N/A
ROA(3y)-188.67%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.1%
GM growth 5YN/A
F-Score4
Asset Turnover1.47
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 103.76%
Cap/Sales 4.35%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.6
Quick Ratio 1.6
Altman-Z -12.9
F-Score4
WACC8.86%
ROIC/WACCN/A
Cap/Depr(3y)128.18%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.85%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-92.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-30.71%
EPS Next Y75.64%
EPS Next 2Y35.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.12%
Revenue growth 3Y13.05%
Revenue growth 5YN/A
Sales Q2Q%-47.23%
Revenue Next Year14.8%
Revenue Next 2Y17.59%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-96.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year80.23%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-487.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-627.85%
OCF growth 3YN/A
OCF growth 5YN/A